Lungwitz Suzanne, Niemeyer Philipp, Maurer Julia, Fritz Jürgen, Albrecht D, Angele Peter, Fickert Stefan, Gelse Kolja, Zinser Wolfgang, Hofmann Gunther O, Spahn Gunter
Praxisklinik für Unfallchirurgie und Orthopädie Eisenach.
Department für Orthopädie und Traumatologie, Universitätsklinikum Freiburg und OCM Klinik GmbH, München.
Z Orthop Unfall. 2019 Oct;157(5):515-523. doi: 10.1055/a-0820-6256. Epub 2019 Feb 8.
This study was aimed to determine the impact of bioregenerative operations in case of degenerative cartilage lesions within the media knee compartment.
The CartilageRegistry DGOU was founded in 2013. At the deadline August 2016 a total of 1847 patients were included. A total of 23.3% (n = 432) was suffering from a degenerative cartilage lesion in the medial compartment. Follow-up was performed after 6, 12, and 24 months (online evaluation). The patients were asked for their subject feeling as well as the KOOS (Knee injury and Osteoarthritis Outcome Score) was determined.
Most of the patients (n = 358) suffered from a single femoral lesion. In 25 cases single tibial and in 49 cases combined defects ("kissing lesions") were addressed by different treatment options: 39.9% autologous chondrocyte transplantation, in 8.1% in combination with a spongiosa plasty. Other treatments were drilling, microfracturing with or without matrix. In 17.9% the surgeons had chosen combined methods. The bioregenerative treatment was combined with a concomitant operation in 39.7% in patients with medial, in 56.0% in patients with a tibial, and in 67.9% in patients with combined defects. The mostly performed additional operations were osteotomies. There were no gender differences at baseline or during follow-up. The history of patients with femoral defects was shorter than in the other groups. The patients with medial defects judged the subjective outcome significant more frequently better after 6, 12, or 24 months compared with the other groups. The KOOS raised from baseline (median 52 points) to a median of 75 after 6, to 78 points after 12, and to 80 points after 24 months. Patients with femoral defects had a better KOOS-outcome in tendency. Revision operations were required in 7.1%.
The treatment of degenerative cartilage lesions (respective early OA) by bioregenerative procedures are well-established measures. These treatments are sufficient to produce high patients' satisfaction and acceptable short/midterm results.
本研究旨在确定生物再生手术对膝关节内侧间室退行性软骨损伤的影响。
软骨注册中心DGOU成立于2013年。截至2016年8月,共纳入1847例患者。其中23.3%(n = 432)患有内侧间室退行性软骨损伤。在6个月、12个月和24个月后进行随访(在线评估)。询问患者的主观感受,并测定膝关节损伤和骨关节炎疗效评分(KOOS)。
大多数患者(n = 358)患有单一的股骨损伤。25例为单一胫骨损伤,49例为联合缺损(“亲吻损伤”),采用不同的治疗方法:39.9%为自体软骨细胞移植,8.1%联合松质骨成形术。其他治疗方法包括钻孔、有或无基质的微骨折。17.9%的外科医生选择了联合方法。生物再生治疗在内侧损伤患者中39.7%与同期手术联合,胫骨损伤患者中56.0%联合,联合缺损患者中67.9%联合。最常进行的附加手术是截骨术。基线时或随访期间无性别差异。股骨缺损患者的病史比其他组短。与其他组相比,内侧缺损患者在6个月、12个月或24个月后更频繁地认为主观结果明显更好。KOOS从基线(中位数52分)在6个月后升至中位数75分,12个月后升至78分,24个月后升至80分。股骨缺损患者的KOOS结果有更好的趋势。7.1%的患者需要翻修手术。
通过生物再生程序治疗退行性软骨损伤(相应的早期骨关节炎)是成熟的措施。这些治疗足以产生较高的患者满意度和可接受的短期/中期结果。